Amneal Pharmaceuticals, Inc. ( AMRX ) revealed a new analysis of the pivotal RISE-PD Phase 3 study on Monday. The data showed that patients who converted to Crexont from immediate release (IR) carbidopa/levodopa (CD/LD) experienced improved sleep quality. These improvements were measured by their Parkinson’s Disease Sleep Scale-2 (PDSS-2) total scores, showing a mean difference of -2.35 (p ...

03:20 PM EDT, 04/07/2025 (MT Newswires) -- European Commission officials are considering 25% tariffs on US goods sold within the bloc to counter President Donald Trump's import duties on steel and aluminum, Reuters reported Monday, citing a document it viewed. The European tariffs would take effect for some goods on May 16, while the levies on other items will become...

03:15 PM EDT, 04/07/2025 (MT Newswires) -- Strategy (MSTR) on Monday reported $5.91 billion in unrealized loss on its digital holdings for the quarter ending March 31, likely resulting in a net loss despite a $1.69 billion income tax benefit. The loss stems from the company's adoption of Accounting Standards Update No. 2023-08, effective Jan. 1, which requires changes in...

03:16 PM EDT, 04/07/2025 (MT Newswires) -- Price: 108.29, Change: +0.29, Percent Change: +0.27 ...